Supernus Pharmaceuticals
SUPN
#4334
Rank
โ‚น167.08 B
Marketcap
โ‚น3,026
Share price
-0.83%
Change (1 day)
33.33%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): โ‚น65.15

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is โ‚น66.74. In 2022 the company made an earnings per share (EPS) of โ‚น95.46 an increase over its 2021 EPS that were of โ‚น86.16.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น65.15-31.75%
2022โ‚น95.4610.78%
2021โ‚น86.16-57.68%
2020โ‚น203.5812.09%
2019โ‚น181.620.47%
2018โ‚น180.7889.38%
2017โ‚น95.46-38.59%
2016โ‚น155.43534.48%
2015โ‚น24.50-211.54%
2014-โ‚น21.96-91.1%
2013-โ‚น246.6739.46%
2012-โ‚น176.88-69.27%
2011-โ‚น575.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,632 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น458.64 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น335.37 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น251.08 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,190 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA